デフォルト表紙
市場調査レポート
商品コード
1439988

脊椎圧迫骨折(VCF)治療装置の世界市場:洞察、競合情勢、市場予測:2030年

Vertebral Compression Fractures (VCF) Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
脊椎圧迫骨折(VCF)治療装置の世界市場:洞察、競合情勢、市場予測:2030年
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脊椎圧迫骨折(VCF)治療装置の市場規模は、2024年から2030年までの予測期間中に7.5%のCAGRで拡大すると予測されています。脊椎圧迫骨折(VCF)治療装置の需要は、主に脊椎圧迫骨折(VCF)の原因となる骨粗鬆症に罹患する患者人口の増加、高齢化、肥満などの関連リスク要因の急増、閉経後女性の人口増加、製品開発における技術革新などが後押ししており、2024年から2030年の予測期間中に脊椎圧迫骨折(VCF)治療装置市場全体の成長に寄与しています。

世界保健機関(WHO)の2022年版によると、筋骨格系の疾患は障害の主な原因であり、世界中で約17億1,000万人が骨粗鬆症、変形性関節症、関節リウマチなどの筋骨格系の疾患に苦しんでいます。

国際骨粗鬆症財団(International Osteoporosis Foundation)2021年版によると、2019年の英国における骨粗鬆症患者は約377万5,000人でした。

骨粗鬆症は骨の微細構造を破壊し、骨基質中の非コラーゲン性タンパク質の含有量を変化させるため、骨密度が低下します。この組織構造の劣化により、骨折しやすい弱い骨になります。

脊椎圧迫骨折(VCF)の最も一般的な病因である骨粗鬆症など、様々な整形外科疾患に罹りやすい高齢者人口の増加は、脊椎圧迫骨折(VCF)治療装置の需要をさらに加速させています。WHOのデータ(2023年)によると、2020年には全世界で約10億人が60歳以上となっています。60歳以上の高齢者人口は2050年までに倍増し、約21億人になると予想されています。また、80歳以上の高齢者人口は2020年から2050年の間に3倍に増え、4億2,600万人に達すると推定されています。

当レポートでは、世界の脊椎圧迫骨折(VCF)治療装置市場について調査し、市場の概要とともに、製品タイプ別、手術タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 脊椎圧迫骨折(VCF)治療装置市場レポートのイントロダクション

第2章 脊椎圧迫骨折(VCF)治療装置市場のエグゼクティブサマリー

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 脊椎圧迫骨折(VCF)治療装置市場の主な要因分析

  • 脊椎圧迫骨折(VCF)治療装置市場の促進要因
  • 脊椎圧迫骨折(VCF)治療装置市場の抑制要因と課題
  • 脊椎圧迫骨折(VCF)治療装置市場の機会

第5章 脊椎圧迫骨折(VCF)治療装置市場におけるポーターのファイブフォース分析

第6章 脊椎圧迫骨折(VCF)治療装置市場の概要

  • 製品タイプ別
  • 手術タイプ別
  • エンドユーザー別
  • 地域別

第7章 脊椎圧迫骨折(VCF)治療装置市場の企業と製品プロファイル

  • IZI Medical
  • Stryker
  • Globus Medical
  • Amber Implants
  • Medtronic
  • SAFE ORTHOPAEDICS

第8章 KOL の見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global (2021-2030)
  • Table 3: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Product Type (2021-2030)
  • Table 4: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Surgery Type (2021-2030)
  • Table 5: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by End-User (2021-2030)
  • Table 6: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Geography (2021-2030)
  • Table 7: Vertebral Compression Fractures (VCF) Treatment Devices Market in North America (2021-2030)
  • Table 8: Vertebral Compression Fractures (VCF) Treatment Devices Market in the US (2021-2030)
  • Table 9: Vertebral Compression Fractures (VCF) Treatment Devices Market in Canada (2021-2030)
  • Table 10: Vertebral Compression Fractures (VCF) Treatment Devices Market in Mexico (2021-2030)
  • Table 11: Vertebral Compression Fractures (VCF) Treatment Devices Market in Europe (2021-2030)
  • Table 12: Vertebral Compression Fractures (VCF) Treatment Devices Market in France (2021-2030)
  • Table 13: Vertebral Compression Fractures (VCF) Treatment Devices Market in Germany (2021-2030)
  • Table 14: Vertebral Compression Fractures (VCF) Treatment Devices Market in the United Kingdom (2021-2030)
  • Table 15: Vertebral Compression Fractures (VCF) Treatment Devices Market in Italy (2021-2030)
  • Table 16: Vertebral Compression Fractures (VCF) Treatment Devices Market in Spain (2021-2030)
  • Table 17: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of Europe (2021-2030)
  • Table 18: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 20: Vertebral Compression Fractures (VCF) Treatment Devices Market in China (2021-2030)
  • Table 21: Vertebral Compression Fractures (VCF) Treatment Devices Market in Japan (2021-2030)
  • Table 22: Vertebral Compression Fractures (VCF) Treatment Devices Market in India (2021-2030)
  • Table 23: Vertebral Compression Fractures (VCF) Treatment Devices Market in Australia (2021-2030)
  • Table 24: Vertebral Compression Fractures (VCF) Treatment Devices Market in South Korea (2021-2030)
  • Table 25: Vertebral Compression Fractures (VCF) Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 26: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of the World (2021-2030)
  • Table 27: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Middle East (2021-2030)
  • Table 28: Vertebral Compression Fractures (VCF) Treatment Devices Market in Africa (2021-2030)
  • Table 29: Vertebral Compression Fractures (VCF) Treatment Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global (2021-2030)
  • Figure 3: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Surgery Type (2021-2030)
  • Figure 5: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by End-User (2021-2030)
  • Figure 6: Vertebral Compression Fractures (VCF) Treatment Devices Market in Global by Geography (2021-2030)
  • Figure 7: Vertebral Compression Fractures (VCF) Treatment Devices Market in North America (2021-2030)
  • Figure 8: Vertebral Compression Fractures (VCF) Treatment Devices Market in the US (2021-2030)
  • Figure 9: Vertebral Compression Fractures (VCF) Treatment Devices Market in Canada (2021-2030)
  • Figure 10: Vertebral Compression Fractures (VCF) Treatment Devices Market in Mexico (2021-2030)
  • Figure 11: Vertebral Compression Fractures (VCF) Treatment Devices Market in Europe (2021-2030)
  • Figure 12: Vertebral Compression Fractures (VCF) Treatment Devices Market in France (2021-2030)
  • Figure 13: Vertebral Compression Fractures (VCF) Treatment Devices Market in Germany (2021-2030)
  • Figure 14: Vertebral Compression Fractures (VCF) Treatment Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Vertebral Compression Fractures (VCF) Treatment Devices Market in Italy (2021-2030)
  • Figure 16: Vertebral Compression Fractures (VCF) Treatment Devices Market in Spain (2021-2030)
  • Figure 17: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of Europe (2021-2030)
  • Figure 18: Vertebral Compression Fractures (VCF) Treatment Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Vertebral Compression Fractures (VCF) Treatment Devices Market in China (2021-2030)
  • Figure 20: Vertebral Compression Fractures (VCF) Treatment Devices Market in Japan (2021-2030)
  • Figure 21: Vertebral Compression Fractures (VCF) Treatment Devices Market in India (2021-2030)
  • Figure 22: Vertebral Compression Fractures (VCF) Treatment Devices Market in Australia (2021-2030)
  • Figure 23: Vertebral Compression Fractures (VCF) Treatment Devices Market in South Korea (2021-2030)
  • Figure 24: Vertebral Compression Fractures (VCF) Treatment Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Vertebral Compression Fractures (VCF) Treatment Devices Market in the Middle East (2021-2030)
  • Figure 27: Vertebral Compression Fractures (VCF) Treatment Devices Market in Africa (2021-2030)
  • Figure 28: Vertebral Compression Fractures (VCF) Treatment Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0669

Vertebral Compression Fractures (VCF) Treatment Devices Market By Product Type (Vertebroplasty Devices And Kyphoplasty Devices), Surgery Type (Open Spine Surgery And Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of osteoporosis and growing postmenopausal women population

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030. The demand for vertebral compression fracture (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from osteoporosis which is responsible for causing vertebral compression fracture (VCF), the surge in number of associated risk factors such as old age, obesity, and others, the growing population of postmenopausal women, and innovation in product development among others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Dynamics:

According to the World Health Organization (WHO) 2022, musculoskeletal conditions are the leading contributor to disability, and worldwide around 1.71 billion people are suffering from musculoskeletal diseases such as osteoporosis, osteoarthritis, rheumatoid arthritis, and others.

As per the International Osteoporosis Foundation 2021, there were around 3,775,000 individuals with osteoporosis in the United Kingdom in 2019.

The 2023 data based on self-reported data from the Australian Bureau of Statistics (ABS) 2017-18 National Health Survey (NHS) presented by the Australian Institute of Health and Welfare stated that an estimated 924,000 Australians have osteoporosis. As per the same source, there were 9,300 hospitalizations with a principal diagnosis of osteoporosis for people aged 45 and over in 2020-21 in Australia.

Because osteoporosis disturbs bone microarchitecture and changes the content of noncollagenous proteins in the bone matrix, bone mineral density is reduced. This tissue structure degradation results in weak bones that are prone to fractures.

The increasing geriatric population prone to various orthopedic disorders including osteoporosis which is the most common etiology of vertebral compression fractures (VCF), and others is further accelerating the demand for vertebral compression fractures (VCF) treatment devices. According to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050. Also, people in the age group of 80 and above are estimated to triple between 2020 and 2050 to reach 426 million.

The growing postmenopausal women population at risk of osteoporotic bone due to hormonal changes is further going to assist in the market growth. As per WHO 2022, in 2021, women aged 50 and over accounted for 26% of all women and girls globally. This was up from 22% 10 years earlier. The menopausal transition most often begins between ages 45 and 55.

However, the occurrence of post-surgical complications, the stringent regulatory approval for the devices, and reimbursement issues may restrict the growth of the overall vertebral compression fractures (VCF) treatment devices market.

Vertebral Compression Fractures (VCF) Treatment Devices Market Segment Analysis:

Vertebral Compression Fractures (VCF) Treatment Devices Market by Product Type (Vertebroplasty Devices and Kyphoplasty Devices), Surgery Type (Open Spine Surgery and Minimally Invasive Spine Surgery), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the vertebral compression fractures (VCF) treatment devices market, the kyphoplasty devices category is expected to amass a significant revenue share in the year 2023. This can be ascribed to the advantages and applications associated with kyphoplasty devices for the effective treatment of vertebral compression fractures (VCF).

Kyphoplasty devices are found to restore vertebral body height and rectify vertebral body deformities. Individuals report a significant and lasting reduction in back discomfort.

Other advantages of kyphoplasty devices include sustained vertebral body height restoration, significant and sustained improvement in quality of life, significant and sustained improvement in mobility, and others.

It reduces the number of days per month when pain interferes with daily activities and improves the overall ability of a person to perform activities walking, hobbies, and work.

A significant reduction in the number of days per month that a patient remains in bed due to back pain is observed after surgery via kyphoplasty devices.

During the surgical procedure, orthopedic balloons are used to restore spinal height and cure angular deformity caused by VCF resulting from osteoporosis, malignancy, or benign lesions. The balloons are deflated and removed after reduction. The cavity formed as a result enables the controlled deposition of bone cement to produce an internal cast and stabilize the fracture.

Therefore, owing to the above-mentioned factors, the kyphoplasty devices category is expected to register significant growth, thereby driving the growth of the overall vertebral compression fractures (VCF) treatment devices market during the forecast period.

North America is expected to dominate the overall Vertebral Compression Fractures (VCF) Treatment Devices Market:

Among all the regions, North America is estimated to account for the largest share of the vertebral compression fractures (VCF) treatment devices market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of various orthopedic disorders, rise in old age population, surge in cases of injuries and fractures due to sudden accidents, high disposable income, sophisticated healthcare infrastructure, presence of key players, increasing product development activities, and others, the market for vertebral compression fractures (VCF) treatment devices is expected to witness prosperity in the region during the forecast period 2024-2030.

Osteoporosis, a disease characterized by weaker bones that tend to break is highly prevalent across the United States. As per the latest data published by the Office of Disease Prevention and Health Promotion, 1 in 10 people aged 50 years have osteoporosis in the United States. The Bone Health & Osteoporosis Foundation's latest data also mentioned about 10 million people in the US having osteoporosis and another 44 million with low bone density, placing them at increased risk. As per the same source, 54 million Americans, half of all adults age 50 and older, are at risk of breaking a bone and should be concerned about bone health.

The increasing age makes one susceptible to several health issues including bone diseases, and others, and thus is another driver for the growth of the vertebral compression fractures (VCF) treatment devices market. According to CDC 2022, around 54.1 million US adults were aged 65 or older in 2019. As per the same source, it has been estimated that by 2060, this number will reach up to 94.7 million in the US.

As per the Administration of Community Living 2021, the population aged 65 and above was 54.1 million, and out of that 30 million were women. Older women are more at risk of suffering from osteoporosis and in turn vertebral compression fractures (VCF).

Thus, the above-mentioned factors are likely to propel the growth of the vertebral compression fractures (VCF) devices market in the region during the forecast period from 2024-2030.

Vertebral Compression Fractures (VCF) Treatment Devices Market Key Players:

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

Recent Developmental Activities in the Vertebral Compression Fractures (VCF) Treatment Devices Market:

IZI Medical Products, LLC ("IZI"), a leading manufacturer of interventional radiology devices and products to treat vertebral compression fractures, launched Vertefix HV Cement ("Vertefix HV"), a unique solution that addresses the need for real-time flow visualization during cement injection for vertebroplasty and kyphoplasty procedures.

In August 2020, IZI Medical Products, LLC announced the official launch of its Osteo-Site Vertebral Balloon ("Osteo-Site Balloon") for vertebral augmentation.

Key Takeaways from the Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Market size analysis for current vertebral compression fractures (VCF) treatment devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global vertebral compression fractures (VCF) treatment devices market.

Various opportunities are available for the other competitors in the vertebral compression fractures (VCF) treatment devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current vertebral compression fractures (VCF) treatment devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for vertebral compression fractures (VCF) treatment devices market growth in the coming future?

Target Audience who can be benefited from this Vertebral Compression Fractures (VCF) Treatment Devices Market Report Study

Vertebral Compression fracture (VCF) Treatment Devices product providers

Research organizations and consulting companies

Vertebral Compression Fractures (VCF) Treatment Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in vertebral compression fractures (VCF) treatment devices

Various End-users who want to know more about the vertebral compression fractures (VCF) treatment devices market and the latest technological developments in the vertebral compression fractures (VCF) treatment devices market.

Frequently Asked Questions for the Vertebral Compression Fractures (VCF) Treatment Devices Market:

1. What is meant by vertebral compression fracture (VCF) treatment devices?

Vertebral compression fractures (VCF) treatment devices are intended for the treatment of vertebral compression fractures (VCF) of the spine.

2. What is the market for global vertebral compression fractures (VCF) devices?

The global vertebral compression fractures (VCF) treatment devices market is estimated to grow at a CAGR of 7.5% during the forecast period from 2024 to 2030.

3. What are the drivers for the global vertebral compression fractures (VCF) devices market?

The demand for vertebral compression fractures (VCF) treatment devices is primarily being boosted by the increasing patient population suffering from various musculoskeletal disorders like osteoporosis and others, the surge in number of risk factors such as old age, obesity, and others associated with causing spinal problems, rising awareness regarding bone health, growing postmenopausal women population, and others, thereby contributing to the overall growth of the vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global vertebral compression fractures (VCF) treatment devices market?

Some of the key market players operating in the vertebral compression fractures (VCF) treatment devices market include Medtronic, Stryker, Globus Medical, IZI Medical, Amber Implants, Safe Orthopaedics, and others.

5. Which region has the highest share in the vertebral compression fractures (VCF) treatment devices market?

North America is expected to dominate the overall vertebral compression fractures (VCF) treatment devices market during the forecast period from 2024-2030. Owing to factors such as the rising prevalence of osteoporosis, surge in the old age population, rise in cases of trauma and fractures, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new products, and high awareness among others, North American vertebral compression fractures (VCF) devices market is expected to growth in coming years.

Table of Contents

1. Vertebral Compression Fractures (VCF) Treatment Devices Market Report Introduction

2. Vertebral Compression Fractures (VCF) Treatment Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Vertebral Compression Fractures (VCF) Treatment Devices Market Key Factors Analysis

  • 4.1. Vertebral Compression Fractures (VCF) Treatment Devices Market Drivers
    • 4.1.1. High prevalence of osteoporosis and other musculoskeletal disorders
    • 4.1.2. Rise in elderly populations, especially postmenopausal women
    • 4.1.3. Increasing accidental injuries and fractures
  • 4.2. Vertebral Compression Fractures (VCF) Treatment Devices Market Restraints and Challenges
    • 4.2.1. Occurrence of post-surgical complications
    • 4.2.2. Stringent regulatory approval for the devices, and reimbursement issues
  • 4.3. Vertebral Compression Fractures (VCF) Treatment Devices Market Opportunities
    • 4.3.1. Increase in awareness about the advancements in spinal surgeries and minimally invasive surgeries
    • 4.3.2. Development of a new generation of injectable bone cement

5. Vertebral Compression Fractures (VCF) Treatment Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Vertebral Compression Fractures (VCF) Treatment Devices Market Layout

  • 6.1. By Product Type
    • 6.1.1. Vertebroplasty Devices
    • 6.1.2. Kyphoplasty Devices
  • 6.2. By Surgery Type
    • 6.2.1. Open Spine Surgery
    • 6.2.2. Minimally Invasive Spine Surgery
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North America Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Vertebral Compression Fractures (VCF) Treatment Devices Market Size in USD million (2021-2030)

7. Vertebral Compression Fractures (VCF) Treatment Devices Market Company and Product Profiles

  • 7.1. IZI Medical
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Stryker
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Globus Medical
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Amber Implants
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Medtronic
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. SAFE ORTHOPAEDICS
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us